Carrier-free nanodrugs with efficient drug delivery and release for cancer therapy: From intrinsic physicochemical properties to external modification-Reference-Cited by-同舟云学术

Carrier-free nanodrugs with efficient drug delivery and release for cancer therapy: From intrinsic physicochemical properties to external modification

Published:2022-02 Issue: Volume:8 Page:220-240
ISSN:2452-199X
Container-title:Bioactive Materials
language:en
Short-container-title:Bioactive Materials

Author:

Mei Heng,Cai Shengsheng,Huang Dennis^ORCID,Gao Huile,Cao Jun,He Bin

Funder

National Natural Science Foundation of China

National Key Research and Development Program of China

Publisher

Elsevier BV

Reference192 articles.

1. Cancer nanomedicine: progress, challenges and opportunities;Shi;Nat. Rev. Canc.,2017

2. Nanomedicine in cancer therapy: challenges, opportunities, and clinical applications;Wicki;J. Contr. Release,2015

3. Exogenous vitamin c triggered structural changes of redox-activated dual core-crosslinked biodegradable nanogels for boosting the antitumor efficiency;Zhu;J. Mater. Chem. B,2020

4. Advanced engineered nanoparticulate platforms to address key biological barriers for delivering chemotherapeutic agents to target sites;Cao;Adv. Drug Deliv. Rev.,2020

5. Cellular internalization of doxorubicin loaded star-shaped micelles with hydrophilic zwitterionic sulfobetaine segments;Cao;Biomaterials,2014

Cited by 168 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advancements in Phytosomal Therapies for Liver Cancer: A Comprehensive Review;Current Cancer Drug Targets;2025-09

2. Biomimetic Ginsenoside Rb1 and Probucol Co-Assembled Nanoparticles for Targeted Atherosclerosis Therapy via Inhibition of Oxidative Stress, Inflammation, and Lipid Deposition;ACS Nano;2025-06-19

3. Advancing immunomodulation in organ transplantation: the therapeutic potential of self-assembled rapamycin nanoparticles in allograft rejection;Journal of Nanobiotechnology;2025-06-05

4. Carrier‐Free Self‐Assembled Nanoparticles for Triple‐Amplified Tumor Chemodynamic Therapy and Cuproptosis Induction;Advanced Healthcare Materials;2025-05-06

5. Sulfafurazole dimers potentiate chemo-immunotherapy of low immunogenic breast cancer by preventing the PD-L1 exosomes secretion;Acta Pharmaceutica Sinica B;2025-05